CurrentPremera BluecrossPolicy N/A

Radiofrequency treatment and ablation for nasal obstruction and nasal swell body reduction

Policy governs coverage determination for radiofrequency volumetric tissue reduction (e.g., VivAer Stylus) for internal nasal valve collapse and radiofrequency or cryoablation for nasal swell body reduction for treatment of nasal obstruction.

Policy Summary

PayerPremera Bluecross

PolicyRadiofrequency treatment and ablation for nasal obstruction and nasal swell body reduction

Policy CodePolicy N/A

Change TypeAnnual literature updatestatements unchanged

Effective DateMay 1, 2026

Next Review Date

Key ActionDocument clinical diagnosis of nasal obstruction and supporting history/physical exam findings (eg, Cottle or modified Cottle maneuver results) to establish etiology such as internal nasal valve collapse or nasal swell body; maintain proper documentation even though procedures are investigational.

SourceLink

POLICY UPDATE CHANGES

Annual review April 13, 2026 updated literature through December 18, 2025; policy statements unchanged.

2Procedures considered investigational

2CPT codes listed

Coverage Summary

Scope: This policy governs coverage determination for radiofrequency volumetric tissue reduction (RFVTR) (e.g., VivAer Stylus) for internal nasal valve collapse and radiofrequency or cryoablation for nasal swell body reduction for treatment of nasal obstruction. Coverage stance: Not covered — procedures considered investigational/cosmetic. Effective date: 2026-05-01. Last review: 2026-04-13.

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Medical-Necessity Determinations

Medically Necessary / Investigational determinations

Policy coverage criteria statements:

ALL of the following

Radiofrequency volumetric tissue reduction for nasal obstruction due to internal nasal valve collapse is considered investigational.
Radiofrequency ablation or cryoablation for nasal swell body reduction for the treatment of nasal obstruction is considered investigational.

Investigational / Not Covered Procedures

Investigational determinations: The evidence is insufficient to determine net health benefit for both interventions. Specifically, evidence for RFVTR includes systematic reviews and one randomized controlled trial with short-term (3-month) benefit but limitations (small size, short duration, confounding) and uncontrolled follow-up; overall strength is insufficient to conclude improvement in net health outcome. Likewise, for nasal swell body reduction (RF ablation, cryoablation, and other reduction methods) studies are small, uncontrolled, or retrospective and do not provide adequate long-term controlled data; overall evidence is insufficient to determine net health benefit.

Provider Actions & Documentation

Documentation Required

Clinical documentation for nasal obstruction diagnosis

Document clinical diagnosis of nasal obstruction and supporting history/physical exam findings (eg, Cottle or modified Cottle maneuver results) to establish etiology such as internal nasal valve collapse or nasal swell body; although the procedures are considered investigational, proper documentation of diagnosis should be maintained.

Procedures (radiofrequency volumetric tissue reduction for internal nasal valve collapse and radiofrequency or cryoablation for nasal swell body reduction) are considered investigational; maintain thorough documentation of diagnosis and findings.

Background

Background: Nasal obstruction can result from internal nasal valve collapse or nasal swell body hypertrophy. Radiofrequency and cryotherapy techniques have been proposed as less invasive alternatives to surgical grafting or excision, aiming to shrink or remodel tissue and improve airflow with shorter recovery. However, these techniques remain investigational because current evidence is not sufficient to demonstrate consistent improvement in health outcomes.

Definitions

Evidence summary

Revision History

2025-05-01added

Initial policy established investigational status for radiofrequency volumetric tissue reduction for nasal obstruction due to internal nasal valve collapse and for radiofrequency ablation or cryoablation for nasal swell body reduction; HCPCS/CPT codes 30117 and 30469 added to coding section.

2026-04-13clarifiedLatest

Annual review updated literature through December 18, 2025 with no changes to coverage statements; references added.